rethinkTHC Search
Menu
Study breakdown

CB1 receptor expression changed in brain immune cells of an Alzheimer's mouse model

AnimalLow evidence
The takeaway

In the subiculum of Alzheimer's disease model mice, CB1 receptor expression increased in reactive microglia but remained proportionally constant in astrocytes, suggesting distinct glial endocannabinoid responses to amyloid pathology.

Neuroscience researchers, Alzheimer's disease specialists, and those studying endocannabinoid system roles in neurodegeneration.

CB1 receptors increased in reactive microglia near amyloid plaques in Alzheimer's mice

What the researchers found

CB1 receptor expression increased in reactive microglia surrounding amyloid plaques in the subiculum of 5xFAD mice. In astrocytes, CB1 labeling rose proportionally to cell size (reactive astrocytes are larger), keeping receptor density effectively constant.

Why it matters

The endocannabinoid system is involved in neuroinflammation, and understanding how CB1 receptors change in glial cells during Alzheimer's pathology could identify therapeutic targets for modulating the neuroinflammatory response.

The numbers in context

CB1 receptor expression increased in reactive microglia in 5xFAD mice vs. controls. In astrocytes, CB1 labeling increased proportionally to perimeter of reactive astrocytes. Microglial CB1 was found closely surrounding amyloid plaques and dystrophic neurites.

How the study worked

Immuno-electron microscopy examining CB1 receptor localization in microglia and astrocytes in the subiculum of 5xFAD/CB2-EGFP mice (Alzheimer's model) versus controls. Quantitative analysis of receptor density relative to glial cell morphology.

What this study cannot tell us

Mouse model of Alzheimer's disease (5xFAD) overexpresses mutant human genes and may not fully recapitulate human AD pathology. Observational study of receptor expression without functional testing. Only examined the subiculum, one of many affected brain regions.

How to read the evidence

Well-executed electron microscopy study in a transgenic mouse model. Descriptive finding without functional or therapeutic testing.

When this study was published

Published 2023.

The bigger picture

Neuroinflammation driven by microglia and astrocytes is increasingly recognized as a key driver of Alzheimer's progression. The endocannabinoid system modulates this inflammatory response, making it a potential intervention point for slowing disease.

Questions still open

  • Does the increase in microglial CB1 expression serve a protective or pathological role? Would CB1 modulation in microglia alter amyloid plaque progression or neuroinflammation?

Common questions

What does this mean for cannabis and Alzheimer's?
This study shows that cannabinoid receptors change in brain immune cells during Alzheimer's-like pathology in mice. It does not test whether cannabis or cannabinoids would help or harm Alzheimer's patients. It identifies the endocannabinoid system as involved in the brain's inflammatory response to amyloid plaques.
What are microglia and why do they matter in Alzheimer's?
Microglia are the brain's resident immune cells. In Alzheimer's disease, they cluster around amyloid plaques and become "reactive," producing inflammatory molecules. This neuroinflammation is thought to accelerate brain damage. Understanding how cannabinoid receptors change in these cells could reveal new ways to modulate the harmful inflammatory response.

Read the original research

Altered glial expression of the cannabinoid 1 receptor in the subiculum of a mouse model of Alzheimer's disease.

Glia, 71(4), 866-879

Citation

Terradillos, Itziar; Bonilla-Del Río, Itziar; Puente, Nagore; Serrano, Maitane; Mimenza, Amaia; Lekunberri, Leire; Anaut-Lusar, Ilazki; Reguero, Leire; Gerrikagoitia, Inmaculada; Ruiz de Martín Esteban, Samuel; Hillard, Cecilia J; Grande, María T; Romero, Julián; Elezgarai, Izaskun; Grandes, Pedro. (2023). Altered glial expression of the cannabinoid 1 receptor in the subiculum of a mouse model of Alzheimer's disease.. Glia, 71(4), 866-879. https://doi.org/10.1002/glia.24312

Explore the wider topic